Engineering strategies and challenges of endolysin as an antibacterial agent against Gram‐negative bacteria
Microbial Biotechnology · 2024-04 · 17 (4)
DOI: 10.1111/1751-7915.14465 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Biotechnology, online erschienen am 09.04.2024. Verfasst von Tianyu Zheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Bathurst Future Agri-Tech Institute, Qingdao Agricultural University, Qingdao, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteriophages. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Science and Technology-based Small and Medium-sized Enterprises Innovation Capacity Enhancement Project of Shandong Province, The Natural Science Foundation of Shandong Province, The Modern Agricultural Technology System Innovation Team of Shandong Province.
Abstract (Originalsprache)
Bacteriophage endolysin is a novel antibacterial agent that has attracted much attention in the prevention and control of drug‐resistant bacteria due to its unique mechanism of hydrolysing peptidoglycans. Although endolysin exhibits excellent bactericidal effects on Gram‐positive bacteria, the presence of the outer membrane of Gram‐negative bacteria makes it difficult to lyse them extracellularly, thus limiting their application field. To enhance the extracellular activity of endolysin and facilitate its crossing through the outer membrane of Gram‐negative bacteria, researchers have adopted physical, chemical, and molecular methods. This review summarizes the characterization of endolysin targeting Gram‐negative bacteria, strategies for endolysin modification, and the challenges and future of engineering endolysin against Gram‐negative bacteria in clinical applications, to promote the application of endolysin in the prevention and control of Gram‐negative bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bathurst Future Agri-Tech Institute, Qingdao Agricultural University, Qingdao, China.
- College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, China.
ORCID-Profile: Tianyu Zheng, Can Zhang
Förderung
- The Science and Technology-based Small and Medium-sized Enterprises Innovation Capacity Enhancement Project of Shandong Province
- The Natural Science Foundation of Shandong Province
- The Modern Agricultural Technology System Innovation Team of Shandong Province
Zitieren
APA
Zheng, T., & Zhang, C. (2024). Engineering strategies and challenges of endolysin as an antibacterial agent against Gram‐negative bacteria. Microbial Biotechnology, 17(4). https://doi.org/10.1111/1751-7915.14465
Vancouver
Zheng T, Zhang C. Engineering strategies and challenges of endolysin as an antibacterial agent against Gram‐negative bacteria. Microbial Biotechnology. 2024;17(4). doi:10.1111/1751-7915.14465
BibTeX
@article{Zheng2024,
author = {Zheng, Tianyu and Zhang, Can},
title = {Engineering strategies and challenges of endolysin as an antibacterial agent against Gram‐negative bacteria},
journal = {Microbial Biotechnology},
year = {2024},
volume = {17},
number = {4},
doi = {10.1111/1751-7915.14465}
}
EUVIMED